Day One Biopharmaceuticals (NASDAQ:DAWN) Price Target Lowered to $34.00 at JPMorgan Chase & Co.
Day One Biopharmaceuticals (NASDAQ:DAWN – Get Free Report) had its target price dropped by JPMorgan Chase & Co. from $39.00 to $34.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 273.63% from the company’s current […]
Day One Biopharmaceuticals (NASDAQ:DAWN – Get Free Report) had its target price dropped by JPMorgan Chase & Co. from $39.00 to $34.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 273.63% from the company’s current […]
